___ Karen L. van Caulil, Ph.D., is the Executive Director of Floridians for Accountability in Health Care. Doug Wheeler is the Director of the George Gibbs Center for Economic Prosperity at The James ...

Key Takeaways - CMS launches Drug Acquisition Cost Survey beginning Jan. 1, 2026. OPPS hospitals must submit NDC-level pricing data for ...

The hospital lobby has filed a lawsuit seeking to block the federal government’s 340B Rebate Model Pilot Program, which is ...

The 340B rebate pilot model set to begin in January 2026 starkly presents the key tradeoff between program integrity and ...

The American Hospital Association and several large hospital systems have filed a lawsuit seeking to halt an upcoming pilot ...

Senate HELP Committee Hearing Highlights Urgent Need to Reform 340B Program — Lawmakers Push for Transparency and Patient ...

The 340B Drug Pricing Program was designed to help safety net providers serve low-income patients, but it has since ballooned into a multibillion-dollar system dominated by large health systems — with ...

Hospitals across Michigan are exploiting a little-known federal program to squeeze millions of dollars out of the state's poorest patients.

AHA Board Chair Tina Freese Decker talks with AHA VP Aimee Kuhlman and Monument Health CEO Paulette Davidson about the benefits of the 340B program.

Under the 340B program, eligible hospitals buy drugs at a discounted price in order to offset the cost of treating low income ...

Without a change, 340B will continue to enrich wealthier entities at the expense of the vulnerable entities while increasing costs for taxpayers.

In this Leadership Dialogue conversation, Tina Freese Decker, president and CEO of Corewell Health and 2025 AHA board chair, joins Aimee Kuhlman, vice president of advocacy grassroots and government ...